Intracytoplasmic filamentous inclusions and IGHV rearrangements in a patient with chronic lymphocytic leukemia
- Autores
- Rodríguez, Cecilia María; Stanganelli, Carmen Graciela; Bussi, Claudio; Arroyo, Daniela Soledad; Sastre, Darío; Heller, Viviana; Iribarren, Pablo; Slavutsky, Irma Rosa
- Año de publicación
- 2018
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Chronic lymphocytic leukemia (CLL) represents the most common leukemia in the Western world, accounting for 30-40% of all adult leukemias. The disease is characterized by a highly variable clinical course, ranging from indolent cases to patients with aggressive and rapidly progressing disease. Although staging systems are reliable predictors of outcome, they do not fully explain the heterogeneity in treatment response and survival. In the last decades, several prognostic biomarkers have been identified, allowing the subdivision of this heterogeneous disease into clinical relevant subgroups. Among them, genomic alterations and the IGHV (immunoglobulin heavy chain variable region) mutational status are of significance. Particularly, recurrent cytogenetic abnormalities namely deletions of chromosomes 11q, 13q and 17p and, trisomy 12, define subgroups of patients with different clinical behavior and response to treatment while IGHV mutational status permits to distinguish two major CLL subtypes, mutated (M) associated with a good prognosis, and unmutated (UM), characterized by a poor clinical evolution.
Fil: Rodríguez, Cecilia María. Universidad Nacional de Córdoba. Facultad de Medicina. Hosp.nacional de Clinicas. Laboratorio de Biología Molecular Citometría de Flujo del Servicio de Oncología y Hematología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina
Fil: Stanganelli, Carmen Graciela. Academia Nacional de Medicina de Buenos Aires. Instituto de Investigaciones Hematológicas ; Argentina
Fil: Bussi, Claudio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina
Fil: Arroyo, Daniela Soledad. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina
Fil: Sastre, Darío. Universidad Nacional de Córdoba. Facultad de Medicina. Hosp.nacional de Clinicas. Laboratorio de Biología Molecular Citometría de Flujo del Servicio de Oncología y Hematología; Argentina
Fil: Heller, Viviana. Universidad Nacional de Córdoba. Facultad de Medicina. Hosp.nacional de Clinicas. Laboratorio de Biología Molecular Citometría de Flujo del Servicio de Oncología y Hematología; Argentina
Fil: Iribarren, Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina
Fil: Slavutsky, Irma Rosa. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina - Materia
-
Cll
Autophagy
Ighv
Leukemia - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/63317
Ver los metadatos del registro completo
id |
CONICETDig_2a491e9eeb86ad1ecae7912541f76ce2 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/63317 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Intracytoplasmic filamentous inclusions and IGHV rearrangements in a patient with chronic lymphocytic leukemiaRodríguez, Cecilia MaríaStanganelli, Carmen GracielaBussi, ClaudioArroyo, Daniela SoledadSastre, DaríoHeller, VivianaIribarren, PabloSlavutsky, Irma RosaCllAutophagyIghvLeukemiahttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Chronic lymphocytic leukemia (CLL) represents the most common leukemia in the Western world, accounting for 30-40% of all adult leukemias. The disease is characterized by a highly variable clinical course, ranging from indolent cases to patients with aggressive and rapidly progressing disease. Although staging systems are reliable predictors of outcome, they do not fully explain the heterogeneity in treatment response and survival. In the last decades, several prognostic biomarkers have been identified, allowing the subdivision of this heterogeneous disease into clinical relevant subgroups. Among them, genomic alterations and the IGHV (immunoglobulin heavy chain variable region) mutational status are of significance. Particularly, recurrent cytogenetic abnormalities namely deletions of chromosomes 11q, 13q and 17p and, trisomy 12, define subgroups of patients with different clinical behavior and response to treatment while IGHV mutational status permits to distinguish two major CLL subtypes, mutated (M) associated with a good prognosis, and unmutated (UM), characterized by a poor clinical evolution.Fil: Rodríguez, Cecilia María. Universidad Nacional de Córdoba. Facultad de Medicina. Hosp.nacional de Clinicas. Laboratorio de Biología Molecular Citometría de Flujo del Servicio de Oncología y Hematología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; ArgentinaFil: Stanganelli, Carmen Graciela. Academia Nacional de Medicina de Buenos Aires. Instituto de Investigaciones Hematológicas ; ArgentinaFil: Bussi, Claudio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; ArgentinaFil: Arroyo, Daniela Soledad. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; ArgentinaFil: Sastre, Darío. Universidad Nacional de Córdoba. Facultad de Medicina. Hosp.nacional de Clinicas. Laboratorio de Biología Molecular Citometría de Flujo del Servicio de Oncología y Hematología; ArgentinaFil: Heller, Viviana. Universidad Nacional de Córdoba. Facultad de Medicina. Hosp.nacional de Clinicas. Laboratorio de Biología Molecular Citometría de Flujo del Servicio de Oncología y Hematología; ArgentinaFil: Iribarren, Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; ArgentinaFil: Slavutsky, Irma Rosa. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; ArgentinaTaylor & Francis Ltd2018-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/63317Rodríguez, Cecilia María; Stanganelli, Carmen Graciela; Bussi, Claudio; Arroyo, Daniela Soledad; Sastre, Darío; et al.; Intracytoplasmic filamentous inclusions and IGHV rearrangements in a patient with chronic lymphocytic leukemia; Taylor & Francis Ltd; Leukemia and Lymphoma; 59; 5; 5-2018; 1239-12431042-81941029-2403CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.tandfonline.com/doi/full/10.1080/10428194.2017.1370549info:eu-repo/semantics/altIdentifier/doi/10.1080/10428194.2017.1370549info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:49:21Zoai:ri.conicet.gov.ar:11336/63317instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:49:21.234CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Intracytoplasmic filamentous inclusions and IGHV rearrangements in a patient with chronic lymphocytic leukemia |
title |
Intracytoplasmic filamentous inclusions and IGHV rearrangements in a patient with chronic lymphocytic leukemia |
spellingShingle |
Intracytoplasmic filamentous inclusions and IGHV rearrangements in a patient with chronic lymphocytic leukemia Rodríguez, Cecilia María Cll Autophagy Ighv Leukemia |
title_short |
Intracytoplasmic filamentous inclusions and IGHV rearrangements in a patient with chronic lymphocytic leukemia |
title_full |
Intracytoplasmic filamentous inclusions and IGHV rearrangements in a patient with chronic lymphocytic leukemia |
title_fullStr |
Intracytoplasmic filamentous inclusions and IGHV rearrangements in a patient with chronic lymphocytic leukemia |
title_full_unstemmed |
Intracytoplasmic filamentous inclusions and IGHV rearrangements in a patient with chronic lymphocytic leukemia |
title_sort |
Intracytoplasmic filamentous inclusions and IGHV rearrangements in a patient with chronic lymphocytic leukemia |
dc.creator.none.fl_str_mv |
Rodríguez, Cecilia María Stanganelli, Carmen Graciela Bussi, Claudio Arroyo, Daniela Soledad Sastre, Darío Heller, Viviana Iribarren, Pablo Slavutsky, Irma Rosa |
author |
Rodríguez, Cecilia María |
author_facet |
Rodríguez, Cecilia María Stanganelli, Carmen Graciela Bussi, Claudio Arroyo, Daniela Soledad Sastre, Darío Heller, Viviana Iribarren, Pablo Slavutsky, Irma Rosa |
author_role |
author |
author2 |
Stanganelli, Carmen Graciela Bussi, Claudio Arroyo, Daniela Soledad Sastre, Darío Heller, Viviana Iribarren, Pablo Slavutsky, Irma Rosa |
author2_role |
author author author author author author author |
dc.subject.none.fl_str_mv |
Cll Autophagy Ighv Leukemia |
topic |
Cll Autophagy Ighv Leukemia |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Chronic lymphocytic leukemia (CLL) represents the most common leukemia in the Western world, accounting for 30-40% of all adult leukemias. The disease is characterized by a highly variable clinical course, ranging from indolent cases to patients with aggressive and rapidly progressing disease. Although staging systems are reliable predictors of outcome, they do not fully explain the heterogeneity in treatment response and survival. In the last decades, several prognostic biomarkers have been identified, allowing the subdivision of this heterogeneous disease into clinical relevant subgroups. Among them, genomic alterations and the IGHV (immunoglobulin heavy chain variable region) mutational status are of significance. Particularly, recurrent cytogenetic abnormalities namely deletions of chromosomes 11q, 13q and 17p and, trisomy 12, define subgroups of patients with different clinical behavior and response to treatment while IGHV mutational status permits to distinguish two major CLL subtypes, mutated (M) associated with a good prognosis, and unmutated (UM), characterized by a poor clinical evolution. Fil: Rodríguez, Cecilia María. Universidad Nacional de Córdoba. Facultad de Medicina. Hosp.nacional de Clinicas. Laboratorio de Biología Molecular Citometría de Flujo del Servicio de Oncología y Hematología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina Fil: Stanganelli, Carmen Graciela. Academia Nacional de Medicina de Buenos Aires. Instituto de Investigaciones Hematológicas ; Argentina Fil: Bussi, Claudio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina Fil: Arroyo, Daniela Soledad. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina Fil: Sastre, Darío. Universidad Nacional de Córdoba. Facultad de Medicina. Hosp.nacional de Clinicas. Laboratorio de Biología Molecular Citometría de Flujo del Servicio de Oncología y Hematología; Argentina Fil: Heller, Viviana. Universidad Nacional de Córdoba. Facultad de Medicina. Hosp.nacional de Clinicas. Laboratorio de Biología Molecular Citometría de Flujo del Servicio de Oncología y Hematología; Argentina Fil: Iribarren, Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Córdoba. Centro de Investigaciones en Bioquímica Clínica e Inmunología; Argentina Fil: Slavutsky, Irma Rosa. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina |
description |
Chronic lymphocytic leukemia (CLL) represents the most common leukemia in the Western world, accounting for 30-40% of all adult leukemias. The disease is characterized by a highly variable clinical course, ranging from indolent cases to patients with aggressive and rapidly progressing disease. Although staging systems are reliable predictors of outcome, they do not fully explain the heterogeneity in treatment response and survival. In the last decades, several prognostic biomarkers have been identified, allowing the subdivision of this heterogeneous disease into clinical relevant subgroups. Among them, genomic alterations and the IGHV (immunoglobulin heavy chain variable region) mutational status are of significance. Particularly, recurrent cytogenetic abnormalities namely deletions of chromosomes 11q, 13q and 17p and, trisomy 12, define subgroups of patients with different clinical behavior and response to treatment while IGHV mutational status permits to distinguish two major CLL subtypes, mutated (M) associated with a good prognosis, and unmutated (UM), characterized by a poor clinical evolution. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-05 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/63317 Rodríguez, Cecilia María; Stanganelli, Carmen Graciela; Bussi, Claudio; Arroyo, Daniela Soledad; Sastre, Darío; et al.; Intracytoplasmic filamentous inclusions and IGHV rearrangements in a patient with chronic lymphocytic leukemia; Taylor & Francis Ltd; Leukemia and Lymphoma; 59; 5; 5-2018; 1239-1243 1042-8194 1029-2403 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/63317 |
identifier_str_mv |
Rodríguez, Cecilia María; Stanganelli, Carmen Graciela; Bussi, Claudio; Arroyo, Daniela Soledad; Sastre, Darío; et al.; Intracytoplasmic filamentous inclusions and IGHV rearrangements in a patient with chronic lymphocytic leukemia; Taylor & Francis Ltd; Leukemia and Lymphoma; 59; 5; 5-2018; 1239-1243 1042-8194 1029-2403 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.tandfonline.com/doi/full/10.1080/10428194.2017.1370549 info:eu-repo/semantics/altIdentifier/doi/10.1080/10428194.2017.1370549 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Taylor & Francis Ltd |
publisher.none.fl_str_mv |
Taylor & Francis Ltd |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842268968784494592 |
score |
13.13397 |